Related by context. Frequent words. (Click for all words.) 61 non alcoholic steatohepatitis 61 hepatitis C HCV 59 organ transplant rejection 58 Torisel 58 arterial thrombosis 58 Hepatitis C HCV 57 Pirfenidone 57 Phase III clinical trials 57 Pivotal Trial 57 idiopathic pulmonary fibrosis IPF 57 Amrubicin 57 chronic HCV infection 56 TORISEL 56 solid organ transplantation 56 Nimotuzumab 56 Clevudine 55 Phase III clinical 55 Phase III Clinical Trial 55 lupus nephritis 55 Icatibant 55 Phase 2b clinical 55 squalamine 55 Diabetic Retinopathy 55 post herpetic neuralgia 55 diabetic macular edema DME 55 phenylketonuria PKU 55 myelodysplastic syndrome MDS 55 Wet AMD 55 Phase 2a clinical 54 postherpetic neuralgia 54 inflammatory autoimmune 54 symptomatic uterine fibroids 54 CMV disease 54 NOXAFIL 54 TYKERB 54 secondary hyperparathyroidism 54 Omigard 54 Diamyd ® 54 bone metastasis 54 overactive bladder OAB 54 SUTENT 54 invasive fungal infections 54 Phenoptin 54 paroxysmal nocturnal hemoglobinuria PNH 54 Periodontal disease 53 SHPT 53 colorectal cancer CRC 53 relapsed multiple myeloma 53 relapsed refractory multiple myeloma 53 Cushing Syndrome 53 CINV 53 placebo controlled clinical 53 macular edema 53 Virulizin R 53 cardiovascular metabolic 53 Pivotal Phase III 53 immunocompromised patients 53 cutaneous T cell 53 Multiple sclerosis MS 53 ozarelix 53 endophthalmitis 53 Phase III trials 53 Phase IIa trial 53 hypersensitivity reaction 53 Keppra R 53 diabetic nephropathy 53 Irinotecan 53 Nexavar ® 53 alvimopan 53 Ischemic 53 acute coronary syndromes ACS 53 Acute Myeloid Leukemia AML 53 Phase 2a trial 53 oral mucositis 52 phase IIa 52 metastatic renal cell carcinoma 52 Apixaban 52 oral calcitonin 52 lymphoma CTCL 52 Pivotal Phase 52 Peripheral Artery Disease 52 pseudobulbar affect PBA 52 AZX# 52 Phase 2b trial 52 Retinopathy 52 ecallantide 52 Age Related Macular 52 ocrelizumab 52 Phase Ib 52 PEG INTRON 52 Stomach cancer 52 Allovectin 7 R 52 systemic lupus erythematosus SLE 52 Ulcerative colitis 52 Ventavis 52 pertuzumab 52 Alemtuzumab 52 Phase 1b trial 52 postmenopausal osteoporosis 52 Orphan Drug Status 52 aHUS